Completed Brain & Nervous System Heart, Stroke & Blood

Control of neuroprotection through NMDA receptor-dependent regulation of antioxidant status.

In plain English

AI plain-English summary

A single brain receptor, the NMDA receptor, can either keep neurons alive or kill them, depending on how strongly it is activated. This creates a fundamental problem for treating stroke and neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. Too little NMDA receptor activity harms brain development, as seen in Foetal Alcohol Syndrome. Too much activity kills neurons during a stroke or in certain neurodegenerative conditions. Yet blocking the receptor outright with drugs is also harmful—the brain needs a moderate level of its activity to survive. The researchers aim to map the specific survival signals triggered by low-level NMDA receptor activation, and then find ways to block only the deadly downstream consequences of overactivation, leaving the receptor itself untouched. If successful, this work could identify new therapeutic targets for stroke—a condition where blood supply to the brain is cut off—and potentially for neurodegenerative diseases. The project also uses stem cell-derived human neurons, which provide a theoretically limitless supply of cells that may better reflect human disease biology than animal models. This is primarily fundamental science: understanding how the brain’s natural neuroprotective mechanisms work, and why they fail.

View original technical description
Nerve cells (neurons) communicate by releasing chemical messengers onto each other, which are detected by specialised receptors. Low-level activation of an important receptor, the NMDA receptor (NMDAR), causes activation of signals that improve a neuron‘s chance of survival. We aim to understand the exact nature of these signals. Understanding the brain‘s natural neuroprotective mechanisms is important, since malfunction of these mechanisms may contribute to neurodegeneration in certain debilitating disorders (e.g.Alzheimer‘s, ALS, Parkinson‘s), and also neurodevelopmental disorders associated with too little NMDAR activity (e.g.Foetal Alcohol Syndrome). In contrast to the beneficial effects of modest NMDAR activity, too much NMDAR activation can kill neurons. This can occur when the brain is starved of blood supply, as happens in a stroke, and can even happen in certain neurodegenerative diseases. However, these disorders cannot be treated by blocking the NMDAR with drugs, since this is harmful too. We will investigate how blocking downstream consequences of NMDAR overactivation, rather than the NMDAR itself, can protect neurons in models of disease and injury, possibly leading to therapeutic targets for stroke or novel treatments. Our investigations will include studies on stem cell-derived human neurons, a theoretically limitless source of neurons with potentially increased relevance to human disease.

View the original record at the funder ↗

Researchers

Giles Hardingham (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

The role of the GluN2A NMDAR subunit in determining synaptic function and plasticity
Neuronal vulnerability to ischaemia: the role of AMPA receptor trafficking.
Modulation of Neurotrophin Signalling by Glycoproteins in the Regenerating Nervous System
Identification of NMDA receptor subunits contributing to midbrain dopaminergic learning and behavioural functions
Novel mechanisms of apoptosis suppression by synaptic activity.

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.